Masupirdine (SUVN-502): A promising clinical candidate for themanagement of agitation in Alzheimer's dementia

Category Primary study
ConferenceAlzheimer's and Dementia
Year 2021
This article has no abstract
Epistemonikos ID: ad5689a022df0e46d363c0a7726937c8d5465e6c
First added on: Oct 18, 2025